결과 페이지 2 - 부문: 보건의료 업종: 의약품 제조업체 - 일반 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (44)
- Helsinki (2)
- HKSE (1)
- IOB (16)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (5)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (4)
- Shenzhen (4)
- Stockholm (3)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Middle (1)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (12)
보건의료 (243)
- {{item.name}}
- 모든 업종
- 보건의료 (243)
의약품 제조업체 - 일반 (243)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novartis AG NVSN.MX | MX$2,338.00 138.44 USD |
0
|
MX$4.49T 265.63B USD | MX$1.00 0.06 USD | MX$2,338.00 138.44 USD | MX$2,338.00 138.44 USD | MX$4.49T 265.63B USD | 17.33 | MX$134.90 7.99 USD | |
| AstraZeneca PLC ZEG.F | €154.00 168.34 USD |
+3.11
|
€238.74B 260.98B USD | €648.00 708.35 USD | €150.00 163.97 USD | €154.00 168.34 USD | €238.74B 260.98B USD | 29.55 | €5.21 5.7 USD | |
| AstraZeneca PLC ZEGA.F | €76.50 83.62 USD |
+5.52
|
€237.19B 259.28B USD | €70.00 76.52 USD | €76.50 83.62 USD | €76.50 83.62 USD | €237.19B 259.28B USD | 29.31 | €2.61 2.85 USD | |
| Roche Holding AG RHO6.F | €37.57 41.07 USD |
+3.07
|
€230.61B 252.09B USD | €20.00 21.86 USD | €37.57 41.07 USD | €37.57 41.07 USD | €230.61B 252.09B USD | 23.92 | €1.57 1.72 USD | |
| Gilead Sciences, Inc. GILD.BA | ARS 44,900.00 53.07 USD |
+3.03
|
ARS 212.72T 251.45B USD | ARS 164.00 0.19 USD | ARS 43,560.00 51.49 USD | ARS 44,900.00 53.07 USD | ARS 212.72T 251.45B USD | 4.93 | ARS 9.10K 10.76 USD | |
| Merck & Co., Inc. MRK.SN | $89.12 — |
+12.61
|
$242.47B — | $0.00 — | $89.12 — | $89.12 — | $242.47B — | 11.78 | $7.56 — | |
| Merck & Co., Inc. MRK.MX | MX$1,645.00 97.4 USD |
+3.01
|
MX$4.09T 242.29B USD | MX$29.00 1.72 USD | MX$1,645.00 97.4 USD | MX$1,645.00 97.4 USD | MX$4.09T 242.29B USD | 11.79 | MX$139.42 8.26 USD | |
| Merck & Co., Inc. MRCK34.SA | R$59.56 12.07 USD |
+3.84
|
R$1.19T 241.7B USD | R$4.07K 824.72 USD | R$57.36 11.63 USD | R$59.56 12.07 USD | R$1.19T 241.7B USD | 11.81 | R$5.04 1.02 USD | |
| Pfizer Inc. PFE.BA | ARS 9,240.00 10.92 USD |
+2.9
|
ARS 200.98T 237.57B USD | ARS 21.56K 25.48 USD | ARS 8,900.00 10.52 USD | ARS 9,255.00 10.94 USD | ARS 200.98T 237.57B USD | 1.90 | ARS 4.85K 5.73 USD | |
| Novartis AG NOTA.F | €111.50 121.88 USD |
+0.9
|
€213.95B 233.87B USD | €2.00 2.19 USD | €107.50 117.51 USD | €111.50 121.88 USD | €213.95B 233.87B USD | 17.61 | €6.33 6.92 USD | |
| Merck & Co., Inc. 6MK.F | €77.80 85.05 USD |
+4.57
|
€194.08B 212.15B USD | €2.81K 3.07K USD | €75.00 81.99 USD | €77.80 85.05 USD | €194.08B 212.15B USD | 11.87 | €6.55 7.16 USD | |
| Merck & Co., Inc. 6MK.DE | €77.50 84.72 USD |
+4.03
|
€193.85B 211.9B USD | €8.49K 9.28K USD | €75.00 81.99 USD | €77.50 84.72 USD | €193.85B 211.9B USD | 11.83 | €6.55 7.16 USD | |
| Merck & Co., Inc. MRK.VI | €77.40 84.61 USD |
+4.03
|
€193.08B 211.06B USD | €140.00 153.04 USD | €75.00 81.99 USD | €77.40 84.61 USD | €193.08B 211.06B USD | 11.85 | €6.53 7.14 USD | |
| Amgen Inc. AMGN.MX | MX$5,990.00 354.68 USD |
0
|
MX$3.23T 190.99B USD | MX$3.00 0.18 USD | MX$5,990.00 354.68 USD | MX$5,990.00 354.68 USD | MX$3.23T 190.99B USD | 25.12 | MX$238.40 14.12 USD | |
| Amgen Inc. AMGN34.SA | R$61.72 12.51 USD |
+1.03
|
R$939.20B 190.36B USD | R$274.00 55.54 USD | R$61.72 12.51 USD | R$61.72 12.51 USD | R$939.20B 190.36B USD | 25.08 | R$2.46 0.5 USD | |
| GSK plc GSK.BA | ARS 17,840.00 21.09 USD |
+1.88
|
ARS 143.38T 169.48B USD | ARS 396.00 0.47 USD | ARS 17,620.00 20.83 USD | ARS 17,890.00 21.15 USD | ARS 143.38T 169.48B USD | 14.49 | ARS 1.23K 1.46 USD | |
| Amgen Inc. AMG.F | €285.00 311.54 USD |
+2.1
|
€153.47B 167.76B USD | €240.00 262.35 USD | €278.65 304.6 USD | €285.00 311.54 USD | €153.47B 167.76B USD | 25.46 | €11.19 12.23 USD | |
| Amgen Inc. AMGN.VI | €284.55 311.05 USD |
+2.78
|
€153.22B 167.5B USD | €101.00 110.41 USD | €279.40 305.42 USD | €284.55 311.05 USD | €153.22B 167.5B USD | 25.45 | €11.18 12.22 USD | |
| Amgen Inc. AMG.DE | €284.25 310.72 USD |
+2.71
|
€153.06B 167.32B USD | €309.00 337.78 USD | €278.35 304.27 USD | €284.25 310.72 USD | €153.06B 167.32B USD | 25.35 | €11.21 12.25 USD | |
| Gilead Sciences, Inc. GILD.MX | MX$2,215.00 131.16 USD |
-3.19
|
MX$2.75T 162.72B USD | MX$10.00 0.59 USD | MX$2,215.00 131.16 USD | MX$2,215.00 131.16 USD | MX$2.75T 162.72B USD | 18.58 | MX$119.20 7.06 USD | |
| Bristol-Myers Squibb Company BMY.BA | ARS 23,630.00 27.93 USD |
+1.5
|
ARS 137.55T 162.59B USD | ARS 857.00 1.01 USD | ARS 23,290.00 27.53 USD | ARS 23,730.00 28.05 USD | ARS 137.55T 162.59B USD | 5.64 | ARS 4.18K 4.94 USD | |
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | |
| Gilead Sciences, Inc. GILD34.SA | R$313.20 63.48 USD |
-1.56
|
R$777.16B 157.52B USD | R$16.00 3.24 USD | R$313.20 63.48 USD | R$313.20 63.48 USD | R$777.16B 157.52B USD | 18.19 | R$17.21 3.49 USD | |
| Pfizer Inc. PFE.MX | MX$457.50 27.09 USD |
+1.75
|
MX$2.60T 154.14B USD | MX$379.00 22.44 USD | MX$449.00 26.59 USD | MX$457.50 27.09 USD | MX$2.60T 154.14B USD | 14.41 | MX$31.74 1.88 USD | |
| Pfizer Inc. PFIZ34.SA | R$33.13 6.71 USD |
+2.41
|
R$757.51B 153.53B USD | R$3.83K 776.89 USD | R$32.25 6.54 USD | R$33.13 6.71 USD | R$757.51B 153.53B USD | 14.46 | R$2.29 0.46 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$146.40B — | $0.00 — | $110.29 — | $110.29 — | $146.40B — | 17.07 | $6.46 — | |
| Gilead Sciences, Inc. GILD.VI | €104.16 113.86 USD |
+2.38
|
€131.63B 143.89B USD | €0.00 0 USD | €102.06 111.57 USD | €104.16 113.86 USD | €131.63B 143.89B USD | 18.63 | €5.59 6.11 USD | |
| Gilead Sciences, Inc. GIS.DE | €104.04 113.73 USD |
+2.3
|
€131.53B 143.78B USD | €624.00 682.12 USD | €101.98 111.48 USD | €104.20 113.9 USD | €131.53B 143.78B USD | 18.61 | €5.59 6.11 USD | |
| Gilead Sciences, Inc. GIS.F | €102.10 111.61 USD |
-0.04
|
€128.52B 140.49B USD | €285.00 311.54 USD | €102.10 111.61 USD | €102.10 111.61 USD | €128.52B 140.49B USD | 18.23 | €5.60 6.12 USD | |
| Pfizer Inc. PFE.VI | €21.41 23.4 USD |
+3.01
|
€124.76B 136.38B USD | €1.03K 1.13K USD | €21.09 23.05 USD | €21.41 23.4 USD | €124.76B 136.38B USD | 14.36 | €1.49 1.63 USD | |
| Sanofi SNW.F | €89.47 97.8 USD |
+3.47
|
€110.40B 120.68B USD | €2.00K 2.19K USD | €86.60 94.67 USD | €89.47 97.8 USD | €110.40B 120.68B USD | 17.07 | €5.24 5.73 USD | |
| Pfizer Inc. PFEB.F | €6.55 7.16 USD |
-9.03
|
€110.18B 120.44B USD | €50.00 54.66 USD | €6.55 7.16 USD | €6.55 7.16 USD | €110.18B 120.44B USD | 12.84 | €0.51 0.56 USD | |
| Sanofi SNW2.F | €44.00 48.1 USD |
+2.33
|
€109.18B 119.35B USD | €20.00 21.86 USD | €43.20 47.22 USD | €44.00 48.1 USD | €109.18B 119.35B USD | 16.79 | €2.62 2.86 USD | |
| Sanofi SANO.VI | €88.35 96.58 USD |
+2.09
|
€108.93B 119.07B USD | €114.00 124.62 USD | €87.85 96.03 USD | €88.50 96.74 USD | €108.93B 119.07B USD | 16.86 | €5.24 5.73 USD | |
| Bristol-Myers Squibb Company BMY.MX | MX$883.30 52.3 USD |
+2.69
|
MX$1.82T 107.93B USD | MX$499.00 29.55 USD | MX$883.30 52.3 USD | MX$884.00 52.34 USD | MX$1.82T 107.93B USD | 16.12 | MX$54.79 3.24 USD | |
| GSK plc G1SK34.SA | R$50.85 10.31 USD |
+3.04
|
R$514.28B 104.24B USD | R$117.00 23.71 USD | R$50.85 10.31 USD | R$50.85 10.31 USD | R$514.28B 104.24B USD | 13.63 | R$3.73 0.76 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | R$250.25 50.72 USD |
0
|
R$513.17B 104.01B USD | R$316.00 64.05 USD | R$250.25 50.72 USD | R$250.25 50.72 USD | R$513.17B 104.01B USD | 15.79 | R$15.84 3.21 USD | |
| GSK plc GSKN.MX | MX$866.15 51.29 USD |
+0.05
|
MX$1.74T 103.05B USD | MX$0.00 0 USD | MX$866.15 51.29 USD | MX$866.15 51.29 USD | MX$1.74T 103.05B USD | 13.42 | MX$64.50 3.82 USD | |
| GSK GLAXF | $23.50 — |
+1.6
|
$94.88B — | $1.13K — | $23.25 — | $23.50 — | $94.88B — | 13.42 | $1.75 — | |
| Bristol-Myers Squibb Company BRM.DE | €41.54 45.41 USD |
+2.71
|
€84.57B 92.44B USD | €3.24K 3.54K USD | €40.65 44.44 USD | €41.54 45.41 USD | €84.57B 92.44B USD | 16.16 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BRM.F | €41.20 45.03 USD |
+0.8
|
€83.86B 91.67B USD | €125.00 136.64 USD | €40.50 44.27 USD | €41.20 45.03 USD | €83.86B 91.67B USD | 16.02 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BMYS.VI | €40.96 44.77 USD |
+1.19
|
€83.38B 91.15B USD | €0.00 0 USD | €40.78 44.58 USD | €40.96 44.77 USD | €83.38B 91.15B USD | 15.93 | €2.57 2.81 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | €41.76 45.65 USD |
+3.37
|
€68.72B 75.13B USD | €50.00 54.66 USD | €41.76 45.65 USD | €41.88 45.78 USD | €68.72B 75.13B USD | 30.93 | €1.35 1.48 USD | |
| Chugai Pharmaceutical CHGCF | $45.50 — |
+0.95
|
$74.88B — | $100.00 — | $45.50 — | $45.50 — | $74.88B — | 28.98 | $1.57 — | |
| Daiichi Sankyo Company, Limited D4S.F | €19.28 21.07 USD |
+5.44
|
€40.21B 43.95B USD | €290.00 317.01 USD | €18.77 20.51 USD | €19.29 21.09 USD | €40.21B 43.95B USD | 22.94 | €0.84 0.92 USD | |
| Biogen Inc. BIIB.BA | ARS 17,960.00 21.23 USD |
+1.07
|
ARS 32.63T 38.57B USD | ARS 215.00 0.25 USD | ARS 17,680.00 20.9 USD | ARS 17,960.00 21.23 USD | ARS 32.63T 38.57B USD | 1.16 | ARS 15.45K 18.26 USD | |
| Bayer Aktiengesellschaft BAYZF | $31.05 — |
+1.67
|
$30.53B — | $2.46K — | $30.97 — | $31.76 — | $30.53B — | 0 | -$4.03 — | |
| Bayer Aktiengesellschaft BAYN.VI | €27.43 29.98 USD |
+3.63
|
€27.44B 29.99B USD | €1.41K 1.54K USD | €26.42 28.88 USD | €27.43 29.98 USD | €27.44B 29.99B USD | 0 | -€3.48 -3.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | €6.45 7.05 USD |
0
|
€26.48B 28.94B USD | €1.80K 1.97K USD | €6.45 7.05 USD | €6.45 7.05 USD | €26.48B 28.94B USD | 0 | -€0.87 -0.9 USD | |
| Bayer Aktiengesellschaft BAYER.BD | HUF 10,100.00 27.93 USD |
0
|
HUF 10.30T 28.49B USD | HUF 25.00 0.07 USD | HUF 10,100.00 27.93 USD | HUF 10,100.00 27.93 USD | HUF 10.30T 28.49B USD | 0 | -HUF 1,347.00 -3.7 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | €45.80 50.07 USD |
+0.44
|
€24.94B 27.26B USD | €20.00 21.86 USD | €45.80 50.07 USD | €45.80 50.07 USD | €24.94B 27.26B USD | 10.67 | €4.29 4.69 USD | |
| Biogen Inc. BIIB.MX | MX$2,790.00 165.2 USD |
0
|
MX$422.93B 25.04B USD | MX$0.00 0 USD | MX$2,790.00 165.2 USD | MX$2,790.00 165.2 USD | MX$422.93B 25.04B USD | 13.79 | MX$202.27 11.98 USD | |
| Biogen Inc. BIIB34.SA | R$137.90 27.95 USD |
-1.1
|
R$121.87B 24.7B USD | R$21.00 4.26 USD | R$137.90 27.95 USD | R$137.90 27.95 USD | R$121.87B 24.7B USD | 14.18 | R$9.72 1.97 USD | |
| Biogen Inc. BIIB.VI | €134.80 147.35 USD |
+0.71
|
€19.78B 21.62B USD | €0.00 0 USD | €134.65 147.19 USD | €135.25 147.85 USD | €19.78B 21.62B USD | 14.21 | €9.48 10.36 USD | |
| Biogen Inc. IDP.DE | €134.70 147.25 USD |
+0.45
|
€19.76B 21.6B USD | €357.00 390.25 USD | €133.25 145.66 USD | €135.75 148.39 USD | €19.76B 21.6B USD | 14.16 | €9.51 10.4 USD | |
| Biogen Inc. IDP.F | €134.25 146.75 USD |
-0.56
|
€19.69B 21.53B USD | €21.00 22.96 USD | €134.25 146.75 USD | €135.10 147.68 USD | €19.69B 21.53B USD | 14.13 | €9.50 10.38 USD | |
| Astellas Pharma ALPMF | $10.80 — |
-1.82
|
$20.05B — | $100.00 — | $10.80 — | $10.80 — | $20.05B — | 24.00 | $0.45 — | |
| Astellas Pharma Inc. YPHA.F | €9.70 10.6 USD |
+2.11
|
€17.37B 18.99B USD | €379.00 414.3 USD | €9.70 10.6 USD | €9.70 10.6 USD | €17.37B 18.99B USD | 24.87 | €0.39 0.43 USD | |
| Astellas Pharma Inc. YPH.F | €9.62 10.52 USD |
-0.99
|
€17.24B 18.84B USD | €50.00 54.66 USD | €9.62 10.52 USD | €9.62 10.52 USD | €17.24B 18.84B USD | 24.67 | €0.39 0.43 USD | |
| Cipla Limited CIPLA.BO | ₹1,514.80 18.33 USD |
+0.07
|
₹1.22T 14.8B USD | ₹89.85K 1.09K USD | ₹1,505.70 18.22 USD | ₹1,517.45 18.36 USD | ₹1.22T 14.8B USD | 22.48 | ₹67.36 0.81 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €51.60 56.41 USD |
+2.38
|
€10.78B 11.78B USD | €0.00 0 USD | €50.55 55.26 USD | €51.60 56.41 USD | €10.78B 11.78B USD | 26.46 | €1.95 2.13 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €51.40 56.19 USD |
+2.29
|
€10.77B 11.77B USD | €55.00 60.12 USD | €49.96 54.61 USD | €51.40 56.19 USD | €10.77B 11.77B USD | 26.49 | €1.94 2.12 USD | |
| Orion Oyj ORINF | $81.30 — |
0
|
$11.16B — | $100.00 — | $81.30 — | $81.30 — | $11.16B — | 26.05 | $3.12 — | |
| CSPC Pharmaceutical Group Limited CVG.F | €0.82 0.9 USD |
-0.27
|
€9.69B 10.6B USD | €2.00K 2.19K USD | €0.82 0.9 USD | €0.82 0.9 USD | €9.69B 10.6B USD | 20.57 | €0.04 0.04 USD | |
| Orion Oyj ORINY | $34.18 — |
+9.73
|
$10.40B — | $2.00 — | $34.18 — | $34.18 — | $10.40B — | 26.49 | $1.29 — | |
| Orion Oyj OFK0.F | €28.80 31.48 USD |
+0.7
|
€8.52B 9.32B USD | €500.00 546.57 USD | €28.80 31.48 USD | €28.80 31.48 USD | €8.52B 9.32B USD | 25.71 | €1.12 1.22 USD | |
| Orion Oyj OFK.F | €57.95 63.35 USD |
-0.17
|
€8.51B 9.3B USD | €24.00 26.24 USD | €57.95 63.35 USD | €57.95 63.35 USD | €8.51B 9.3B USD | 25.98 | €2.23 2.44 USD | |
| Grifols, S.A. G0F.F | €5.55 6.07 USD |
+11.9
|
€7.62B 8.33B USD | €68.00 74.33 USD | €5.10 5.57 USD | €5.55 6.07 USD | €7.62B 8.33B USD | 20.55 | €0.27 0.3 USD | |
| Grifols, S.A. GIKLY | $6.70 — |
-2.19
|
$8.32B — | $50.00 — | $6.70 — | $6.70 — | $8.32B — | 20.93 | $0.32 — | |
| Grifols GIFLF | $14.00 — |
+0.72
|
$8.31B — | $500.00 — | $14.00 — | $14.00 — | $8.31B — | 27.45 | $0.51 — | |
| Grifols, S.A. GIFOF | $8.25 — |
-6.41
|
$8.05B — | $4.41K — | $8.18 — | $8.25 — | $8.05B — | 15.86 | $0.52 — | |
| Grifols, S.A. OZTA.F | €10.83 11.83 USD |
+3.44
|
€7.05B 7.7B USD | €175.00 191.3 USD | €10.68 11.67 USD | €10.83 11.83 USD | €7.05B 7.7B USD | 19.68 | €0.55 0.6 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | €13.40 14.65 USD |
-0.74
|
€7.01B 7.67B USD | €15.00 16.4 USD | €13.40 14.65 USD | €13.50 14.76 USD | €7.01B 7.67B USD | 32.68 | €0.41 0.45 USD | |
| Abbott India Limited ABBOTINDIA.BO | ₹29,543.55 357.43 USD |
+0.16
|
₹627.78B 7.6B USD | ₹265.00 3.21 USD | ₹29,363.05 355.24 USD | ₹29,756.05 360 USD | ₹627.78B 7.6B USD | 41.55 | ₹710.87 8.6 USD | |
| Grifols, S.A. GRF.VI | €10.54 11.52 USD |
+0.67
|
€6.86B 7.5B USD | €0.00 0 USD | €10.54 11.52 USD | €10.72 11.71 USD | €6.86B 7.5B USD | 19.16 | €0.55 0.6 USD | |
| Kyowa Kirin KYKOF | $13.58 — |
0
|
$7.11B — | $100.00 — | $13.58 — | $13.58 — | $7.11B — | 28.29 | $0.48 — | |
| Grifols, S.A. G0FB.F | €7.20 7.87 USD |
-4.64
|
€6.50B 7.1B USD | €300.00 327.94 USD | €7.20 7.87 USD | €7.20 7.87 USD | €6.50B 7.1B USD | 13.09 | €0.55 0.6 USD | |
| Ono Pharmaceutical OPHLF | $12.22 — |
+0.16
|
$5.86B — | $104.00 — | $12.22 — | $12.22 — | $5.86B — | 16.73 | $0.73 — | |
| Ono Pharmaceutical Co., Ltd. ON4.F | €10.50 11.48 USD |
-0.94
|
€4.93B 5.39B USD | €75.00 81.99 USD | €10.50 11.48 USD | €10.80 11.81 USD | €4.93B 5.39B USD | 16.66 | €0.63 0.69 USD | |
| Ono Pharmaceutical Co., Ltd. ON4.MU | €10.50 11.48 USD |
-0.94
|
€4.93B 5.39B USD | €0.00 0 USD | €10.50 11.48 USD | €10.70 11.7 USD | €4.93B 5.39B USD | 16.66 | €0.63 0.69 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,476.30 29.96 USD |
-2.5
|
₹433.45B 5.24B USD | ₹255.73K 3.09K USD | ₹2,467.50 29.85 USD | ₹2,550.70 30.86 USD | ₹433.45B 5.24B USD | 43.92 | ₹56.38 0.68 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,476.75 29.96 USD |
-2.5
|
₹433.44B 5.24B USD | ₹4.67K 56.5 USD | ₹2,468.00 29.86 USD | ₹2,565.00 31.03 USD | ₹433.44B 5.24B USD | 43.92 | ₹56.39 0.68 USD | |
| Santen Pharmaceutical SNPHF | $12.64 — |
+25.02
|
$4.11B — | $200.00 — | $12.46 — | $12.64 — | $4.11B — | 21.06 | $0.60 — | |
| Gland Pharma Limited GLAND.NS | ₹1,851.20 22.4 USD |
-1.59
|
₹312.75B 3.78B USD | ₹26.60K 321.79 USD | ₹1,842.50 22.29 USD | ₹1,896.90 22.95 USD | ₹312.75B 3.78B USD | 38.59 | ₹47.97 0.58 USD | |
| Gland Pharma Limited GLAND.BO | ₹1,849.25 22.37 USD |
-1.72
|
₹312.34B 3.78B USD | ₹1.95K 23.53 USD | ₹1,843.00 22.3 USD | ₹1,906.45 23.06 USD | ₹312.34B 3.78B USD | 38.54 | ₹47.98 0.58 USD | |
| Virbac SA VIRP.PA | €354.50 387.52 USD |
+2.6
|
€3.05B 3.33B USD | €3.68K 4.02K USD | €345.00 377.13 USD | €354.50 387.52 USD | €3.05B 3.33B USD | 22.30 | €15.89 17.37 USD | |
| Virbac SA 0NM7.IL | €354.75 387.79 USD |
+2.53
|
€3.02B 3.3B USD | €175.00 191.3 USD | €346.50 378.77 USD | €354.50 387.52 USD | €3.02B 3.3B USD | 25.35 | €13.99 15.29 USD | |
| Virbac SA V16.F | €347.50 379.86 USD |
+0.29
|
€2.98B 3.26B USD | €117.00 127.9 USD | €338.50 370.03 USD | €347.50 379.86 USD | €2.98B 3.26B USD | 21.89 | €15.87 17.35 USD | |
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.45 9.24 USD |
+1.2
|
€2.79B 3.04B USD | €23.00 25.14 USD | €8.45 9.24 USD | €8.45 9.24 USD | €2.79B 3.04B USD | 16.25 | €0.52 0.57 USD | |
| PT Kalbe Farma Tbk PTKFF | $0.06 — |
-21.95
|
$2.84B — | $4.00K — | $0.06 — | $0.06 — | $2.84B — | 0 | $0.00 — | |
| Pfizer Limited PFIZER.NS | ₹4,997.00 60.46 USD |
-2.78
|
₹231.67B 2.8B USD | ₹18.68K 226.03 USD | ₹4,982.50 60.28 USD | ₹5,144.50 62.24 USD | ₹231.67B 2.8B USD | 28.26 | ₹176.82 2.14 USD | |
| Pfizer Limited PFIZER.BO | ₹4,996.20 60.45 USD |
-2.91
|
₹231.35B 2.8B USD | ₹1.12K 13.5 USD | ₹4,988.00 60.35 USD | ₹5,140.00 62.19 USD | ₹231.35B 2.8B USD | 28.30 | ₹176.51 2.14 USD | |
| Haw Par Corporation Limited HAWPY | $46.98 — |
-7.52
|
$2.60B — | $10.00 — | $46.98 — | $46.98 — | $2.60B — | 13.53 | $3.47 — | |
| Haw Par HAWPF | $10.62 — |
-5.43
|
$2.57B — | $100.00 — | $10.62 — | $10.62 — | $2.57B — | 12.20 | $0.87 — | |
| Organon & Co. OGN.MX | MX$138.00 8.17 USD |
0
|
MX$36.98B 2.19B USD | MX$10.27K 607.81 USD | MX$138.00 8.17 USD | MX$138.00 8.17 USD | MX$36.98B 2.19B USD | 3.91 | MX$35.23 2.09 USD | |
| Organon & Co. 7XP.F | €6.45 7.05 USD |
-3.59
|
€1.68B 1.83B USD | €171.00 186.93 USD | €6.34 6.93 USD | €6.63 7.25 USD | €1.68B 1.83B USD | 3.90 | €1.65 1.8 USD | |
| Luye Pharma Group Ltd. LUP.F | €0.34 0.37 USD |
-0.59
|
€1.39B 1.52B USD | €20.00 21.86 USD | €0.34 0.37 USD | €0.34 0.37 USD | €1.39B 1.52B USD | 33.79 | €0.01 0.01 USD | |
| Sanofi India Limited SANOFI.BO | ₹4,586.95 55.49 USD |
-0.23
|
₹109.84B 1.33B USD | ₹605.00 7.32 USD | ₹4,575.50 55.36 USD | ₹4,608.55 55.76 USD | ₹109.84B 1.33B USD | 29.69 | ₹154.47 1.87 USD | |
| Sanofi India Limited SANOFI.NS | ₹4,583.80 55.46 USD |
-0.3
|
₹109.76B 1.33B USD | ₹9.43K 114.06 USD | ₹4,570.10 55.29 USD | ₹4,611.10 55.79 USD | ₹109.76B 1.33B USD | 29.67 | ₹154.48 1.87 USD | |
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
||||||||||
- {{ link.label }} {{link}}